Celebrity Name: Cristiano Ronaldo
Brand Name: Herbalife / Pro2col Technology (HBL Pro2col Software LLC)
Deal Type: Equity Investment (10% Stake) + Brand Ambassador / Sponsorship Rights
Announced: February 17, 2026
Impact: Deepens a decade-long ambassador deal into ownership, strengthens Herbalife’s push into AI-powered personalized wellness, and signals the growing shift of top athletes from pure endorsements to investor–operator roles.
- Cristiano Ronaldo has invested $7.5 million for a 10% equity stake in HBL Pro2col Software, LLC; a Herbalife subsidiary developing an AI-driven personalized nutrition and wellness platform.
- The deal deepens a partnership that began in 2013, officially upgrading Ronaldo’s role from global brand ambassador to co-owner of the platform.
- Following the announcement, Herbalife’s stock (NYSE: HLF) surged up to 19%, reaching $19.75 per share, while the company also reported a 6.3% Q4 revenue increase that beat analyst estimates
Cristiano Ronaldo has taken his long-running partnership with Herbalife to a new level, investing $7.5 million for a 10% equity stake in HBL Pro2col Software LLC, the company’s new AI-powered wellness platform.
It’s a major upgrade from his brand ambassador role, which started back in 2013.
“After more than a decade together… investing in Pro2col felt like a natural evolution,” Ronaldo said, adding that he wants to help “shape and grow a platform that can truly change how people engage with their health and wellness.” His investment also includes a commitment to provide ongoing services and sponsorship rights to the platform.
So what exactly is Pro2col? It’s a smart health app that uses your personal data (sleep quality, nutrition goals, and activity levels) to build a customized wellness plan just for you.
At its core is Pro2Score, a proprietary scoring system that tracks key health metrics and delivers actionable, real-time insights. The platform is currently in beta rollout in the US, Canada, and Puerto Rico, with EMEA market expansion planned for later in 2026.
Wall Street noticed. Herbalife’s stock surged as high as 19% on the news, reaching $19.75, while Q4 results showed 6.3% revenue growth, beating analyst estimates.
“His investment reflects a shared belief in the power of nutrition, data, AI, and personalized insights to drive better health outcomes,” said Herbalife CEO Stephan Gratziani.
Ronaldo, 41, remains the world’s highest-paid footballer and is still starring for Saudi club Al-Nassr. Off the pitch, his investment moves have been just as sharp.
In December 2025, he took a stake in AI search startup Perplexity AI, and in May 2024, became an investor and global ambassador for wearable tech company WHOOP, joining a roster that includes Patrick Mahomes and Michael Phelps.
Just like with Herbalife, both deals started as endorsements before evolving into equity, a pattern CR7 is clearly doubling down on.
Takeaways:
Ronaldo isn’t just putting his face on products anymore; he’s buying a piece of them. This Herbalife deal signals a clear, deliberate strategy: turn long-term endorsements into ownership positions, especially in health, AI, and lifestyle tech.
For Herbalife, it couldn’t come at a better time. Pro2col is still in beta, and having the world’s most-followed athlete as an actual co-owner, not just a marketing face, sends a powerful signal to distributors, customers, and the investment community.
There’s also a global growth angle here. Ronaldo’s massive fanbase in the Middle East, Europe, and Latin America maps almost perfectly onto the markets where Herbalife wants to expand Pro2col next. This isn’t just a check, it’s a distribution strategy.
Are we entering a new era where elite athletes demand equity stakes, not just endorsement paychecks, just like Giannis Antetokounmpo did with Gopuff? Does Ronaldo’s ownership in Pro2col make you more likely to trust or try Herbalife’s digital wellness platform?
